A biopsy from a skeletal metastasis was then obtained after palliative surgery for the establishment of the PDC and the expression of the ASPS1-TFE3 fusion protein was confirmed by PLA in 95% of the patient-derived sarcoma cells (Fig. 3b). This evidence concerns the gene TFE3 and sarcoma.